Table 3.
With metabolic syndrome (29 events)
|
Without metabolic syndrome (39 events)
|
|||
---|---|---|---|---|
Univariate OR (95% CI) | Multivariate OR (95% CI) | Univariate OR (95% CI) | Multivariate OR (95% CI) | |
n | 221 | 342 | ||
IL-18 >277 pg/ml | 3.6 (1.4–9.3)* | 2.9 (1.1–7.8)† | 1.3 (0.66–2.6) | |
IL-6 >1.53 pg/ml | 3.5 (1.4–8.6)* | 2.5 (0.97–6.6) | 1.5 (0.76–3.0) | |
CRP >3.29 mg/l | 3.6 (1.4–9.1)* | 2.5 (0.89–6.9) | 3.8 (1.8–8.1)* | 3.3 (1.5–7.3)* |
Systolic blood pressure >148 mmHg | 2.0 (0.85–4.5) | 2.8 (1.4–5.6)* | 3.1 (1.4–6.5)* | |
Smoking (yes/no) | 1.8 (0.83–4.1) | 2.0 (1.0–3.9)† | 2.5 (1.1–5.3)† | |
Fasting glucose >6.2 mmol/l | 2.1 (0.97–4.7) | 1.8 (0.75–4.5) | ||
Previous CVD | 1.3 (0.59–3.0) | 1.6 (0.81–3.3) | ||
Diet intervention (yes/no) | 0.95 (0.44–2.0) | 0.57 (0.28–1.1) |
Cholesterol, age, triglycerides, BMI, statin use, ACE inhibitors, and n-3 PUFA intervention were excluded from the model (P > 0.25 in univariate analysis). Cutoffs are as described in Statistics.
P < 0.01;
P < 0.05.